Figure 1

Activation of NF-κB p65 in the PBMCs of malaria patients determined by ELISA. (A) Total NF-κB level in the PBMCs of malaria patients (n = 5 for each group). No difference in total-NF-κB p65 level was observed in PBMCs of all malaria patient groups, p > 0.05 compared with healthy controls (Student t-test). (B) Phospho-NF-κB p65 levels in the PBMCs of malaria patients on day 0 and day 7 (n = 11 for each group). Protein extract from PBMCs stimulated with 50 ng/ml of TNF for 30 min was used as a positive control. *Significance of p < 0.05 compared with healthy controls (Student t-test),^†Significance of p < 0.05 compared with the day of admission (Student t-test). Data are presented as a mean ± SEM,.